Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic …

EM Hylek, C Held, JH Alexander, RD Lopes… - Journal of the American …, 2014 - jacc.org
Objectives: This study sought to characterize major bleeding on the basis of the components
of the major bleeding definition, to explore major bleeding by location, to define 30-day …

Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation: The …

S Apostolakis, DA Lane, Y Guo, H Buller… - Journal of the American …, 2012 - jacc.org
Objectives: The objective of this study was to compare the predictive performance of
bleeding risk–estimation tools in a cohort of patients with atrial fibrillation (AF) undergoing …

The HAS‐BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: a systematic review and meta‐analysis

W Zhu, W He, L Guo, X Wang, K Hong - Clinical cardiology, 2015 - Wiley Online Library
Our objective was to compare the diagnostic accuracy between the HAS‐BLED score and
any of HEMORR2HAGES, ATRIA, CHADS2, or CHA2DS2‐VASc scores in anticoagulated …

Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control

AC Skanes, JS Healey, JA Cairns, P Dorian… - Canadian Journal of …, 2012 - Elsevier
Abstract The Canadian Cardiovascular Society (CCS) published the complete set of 2010
Atrial Fibrillation (AF) Guidelines in the January, 2011 issue of the Canadian Journal of …

Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment

FA Klok, V Hösel, A Clemens, WD Yollo… - European …, 2016 - Eur Respiratory Soc
Attempts at identifying patients with an elevated risk of bleeding while on anticoagulation
following acute venous thromboembolism (VTE) have largely been unsuccessful thus far …

Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis

D Zimmerman, MM Sood, C Rigatto… - Nephrology Dialysis …, 2012 - academic.oup.com
Background The reported incidence, prevalence and outcomes of atrial fibrillation (AF) in
patients with end-stage renal disease (ESRD) are variable. The risks and benefits of …

Hypertension and cardiac arrhythmias: a consensus document from the European heart rhythm association (EHRA) and ESC Council on hypertension, endorsed by …

GYH Lip, A Coca, T Kahan, G Boriani, AS Manolis… - Ep …, 2017 - academic.oup.com
Hypertension is a common cardiovascular risk factor leading to heart failure (HF), coronary
artery disease, stroke, peripheral artery disease and chronic renal insufficiency …

Epidemiology and mechanisms of uremia-related cardiovascular disease

M Tonelli, SA Karumanchi, R Thadhani - Circulation, 2016 - Am Heart Assoc
Patients with chronic kidney disease and end-stage renal disease are at 5-to 10-fold higher
risk for developing cardiovascular disease (CVD) than age-matched controls. Clinically …

[HTML][HTML] 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation

CE Chiang, K Okumura, S Zhang, TF Chao, CW Siu… - Journal of arrhythmia, 2017 - Elsevier
Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in
mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050 …

[PDF][PDF] Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS

S Benussi, D Kotecha, A Ahlsson… - Rev Esp …, 2017 - sedeelectronica.comcordoba.com
Se recomienda a los profesionales de la salud que tengan en consideración la presente
guía de la ESC/EACTS en la toma de decisiones clínicas en su ejercicio diario, así como en …